Literature DB >> 11393108

Antibiotic use in public hospitals in Taiwan after the implementation of National Health Insurance.

S C Chang1, Y C Chen, O Y Hu.   

Abstract

BACKGROUND AND
PURPOSE: Only limited data is available on the patterns of antibiotic use in hospitals in Taiwan before and after the implementation of national health insurance. This study aimed to determine the patterns of use of antibiotics in public hospitals in Taiwan after the implementation of the National Health Insurance program and to compare these with patterns prior to the implementation.
METHODS: Data on the annual use of all antibiotics in public hospitals in Taiwan during the period from fiscal year (FY) 1994-1995 to 1997-1998 were collected and analyzed. Hospitals included seven medical centers, 19 regional hospitals, 53 district hospitals, and eight specialty service hospitals.
RESULTS: The annual cost of antibiotics made up 17.4% of the annual cost of all medication used in these hospitals in FY 1994-1995, and decreased year by year to 12.6% in FY 1997-1998. During the study period, 57.4% of the total cost of antibiotics were incurred by medical centers, 24.6% by regional hospitals, 16.2% by district hospitals, and 1.8% by specialty service hospitals. The most commonly used class of antibiotic was cephalosporins, accounting for 48.0% to 54.3% of total antibiotic costs. The second most commonly used class of antibiotic was penicillins, accounting for 15.9% to 17.4% of total antibiotic costs. In FY 1994-1995, the next most commonly used classes of antibiotics were aminoglycosides, fluoroquinolones, and other beta-lactams, respectively, but by FY 1997-1998 these had changed to fluoroquinolones, glycopeptides, and aminoglycosides, respectively. Among the various cephalosporins used, first-generation cephalosporins accounted for 76.1% of all cephalosporins used in FY 1994-1995, which increased year by year to 84.0% in FY 1997-1998. Second-generation cephalosporins accounted for 20.7% of all cephalosporins used in FY 1994-1995, decreasing to 13.2% in FY 1997-1998.
CONCLUSION: The introduction of the National Health Insurance program in Taiwan brought about a major change in antibiotic use patterns in public hospitals.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11393108

Source DB:  PubMed          Journal:  J Formos Med Assoc        ISSN: 0929-6646            Impact factor:   3.282


  7 in total

1.  Molecular epidemiology of clinical isolates of methicillin-resistant Staphylococcus aureus in Taiwan.

Authors:  Yhu-Chering Huang; Lin-Hui Su; Tsu-Lan Wu; Chun-Eng Liu; Tzuu-Guang Young; Po-Yen Chen; Po-Ren Hseuh; Tzou-Yien Lin
Journal:  J Clin Microbiol       Date:  2004-01       Impact factor: 5.948

2.  Information technology facilitates cost-effectiveness analysis in developing countries: an observational study of breast cancer chemotherapy in Taiwan.

Authors:  Ya-Chen Tina Shih; I-Wen Pan; Yi-Wen Tsai
Journal:  Pharmacoeconomics       Date:  2009       Impact factor: 4.981

3.  Telithromycin- and fluoroquinolone-resistant Streptococcus pneumoniae in Taiwan with high prevalence of resistance to macrolides and beta-lactams: SMART program 2001 data.

Authors:  Po-Ren Hsueh; Lee-Jene Teng; Tsu-Lan Wu; Dine Yang; Wen-Kuei Huang; Jainn-Ming Shyr; Yin-Ching Chuang; Jen-Hsien Wan; Jing-Jou Yan; Jang-Jih Lu; Jiunn-Jong Wu; Wen-Chien Ko; Feng-Yee Chang; Yi-Chueh Yang; Yeu-Jun Lau; Yung-Ching Liu; Chun-Ming Lee; Hsieh-Shong Leu; Cheng-Yi Liu; Kwen-Tay Luh
Journal:  Antimicrob Agents Chemother       Date:  2003-07       Impact factor: 5.191

4.  The Primary Resistance of Helicobacter pylori in Taiwan after the National Policy to Restrict Antibiotic Consumption and Its Relation to Virulence Factors-A Nationwide Study.

Authors:  Jyh-Ming Liou; Chi-Yang Chang; Mei-Jyh Chen; Chieh-Chang Chen; Yu-Jen Fang; Ji-Yuh Lee; Jeng-Yih Wu; Jiing-Chyuan Luo; Tai-Cherng Liou; Wen-Hsiung Chang; Cheng-Hao Tseng; Chun-Ying Wu; Tsung-Hua Yang; Chun-Chao Chang; Hsiu-Po Wang; Bor-Shyang Sheu; Jaw-Town Lin; Ming-Jong Bair; Ming-Shiang Wu
Journal:  PLoS One       Date:  2015-05-05       Impact factor: 3.240

5.  Government policy interventions to reduce human antimicrobial use: A systematic review and evidence map.

Authors:  Susan Rogers Van Katwyk; Jeremy M Grimshaw; Miriam Nkangu; Ranjana Nagi; Marc Mendelson; Monica Taljaard; Steven J Hoffman
Journal:  PLoS Med       Date:  2019-06-11       Impact factor: 11.069

6.  Aminoglycoside-associated nonsyndromic deafness and speech disorder in mitochondrial A1555G mutation in a family: A case report.

Authors:  Yang-Hao Ou; Andy Wei-Ge Chen; Jun-Yang Fan; Wen-Ling Cheng; Ta-Tsung Lin; Mu-Kuan Chen; Chin-San Liu
Journal:  Medicine (Baltimore)       Date:  2018-10       Impact factor: 1.817

7.  Identifying key influences on antibiotic use in China: a systematic scoping review and narrative synthesis.

Authors:  Caroline Coope; Annegret Schneider; Tingting Zhang; Paul Kadetz; Rui Feng; Helen Lambert; DeBin Wang; Isabel Oliver; Susan Michie; Christie Cabral
Journal:  BMJ Open       Date:  2022-03-25       Impact factor: 2.692

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.